The expanding demand for controlled immunological investigation and therapeutic design has spurred significant improvements in recombinant growth factor production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently generated using multiple expression systems, including prokaryotic hosts, animal cell populations,